title: Bcr-Abl mutations, resistance to imatinib, and imatinib plasma levels.
authors.forename: Carlo
authors.initials: C
authors.lastname: Gambacorti-Passerini
authors.forename: Rocco
authors.initials: R
authors.lastname: Piazza
authors.forename: Maurizio
authors.initials: M
authors.lastname: D'Incalci
mesh_terms: D000970:Antineoplastic Agents / Q000097:blood* / Q000627:therapeutic use*; D001549:Benzamides; D019008:Drug Resistance, Neoplasm; D016313:Genes, abl / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000097:blood* / Q000627:therapeutic use*; D011743:Pyrimidines / Q000097:blood* / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate